T. Rowe Price Associates’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,810
| Closed | -$20K | – | 2957 |
|
|
2022
Q3 | $20K | Buy |
1,810
+1,498
| +480% | +$16.6K | ﹤0.01% | 2909 |
|
|
2022
Q2 | $5K | Sell |
312
-2,307
| -88% | -$37K | ﹤0.01% | 2941 |
|
|
2022
Q1 | $180K | Sell |
2,619
-872
| -25% | -$59.9K | ﹤0.01% | 2730 |
|
|
2021
Q4 | $211K | Buy |
3,491
+803
| +30% | +$48.5K | ﹤0.01% | 2730 |
|
|
2021
Q3 | $352K | Buy |
2,688
+1,552
| +137% | +$203K | ﹤0.01% | 2517 |
|
|
2021
Q2 | $301K | Buy |
1,136
+269
| +31% | +$71.3K | ﹤0.01% | 2591 |
|
|
2021
Q1 | $292K | Buy |
867
+163
| +23% | +$54.9K | ﹤0.01% | 2569 |
|
|
2020
Q4 | $238K | Buy |
704
+401
| +132% | +$136K | ﹤0.01% | 2504 |
|
|
2020
Q3 | $114K | Sell |
303
-5,078
| -94% | -$1.91M | ﹤0.01% | 2498 |
|
|
2020
Q2 | $2.83M | Buy |
+5,381
| New | +$2.83M | ﹤0.01% | 1464 |
|
|
2019
Q4 | – | Sell |
-1,256
| Closed | -$239K | – | 2532 |
|
|
2019
Q3 | $239K | Sell |
1,256
-3,733
| -75% | -$710K | ﹤0.01% | 2350 |
|
|
2019
Q2 | $1.59M | Sell |
4,989
-378
| -7% | -$120K | ﹤0.01% | 1662 |
|
|
2019
Q1 | $2.22M | Sell |
5,367
-594
| -10% | -$245K | ﹤0.01% | 1564 |
|
|
2018
Q4 | $1.46M | Sell |
5,961
-2,269
| -28% | -$554K | ﹤0.01% | 1659 |
|
|
2018
Q3 | $4.06M | Buy |
+8,230
| New | +$4.06M | ﹤0.01% | 1480 |
|